Widespread bacterial resistance has led to more difficult to treat infectious diseases with available antibiotics. Therefore, new antibiotics are needed face of the growing antibiotic resistance. Swietenia mahagoni (L.) Jacq. is one of potential medicinal plants as a source new antibiotics. Five compounds have been isolated from an ethanolic extract of S. mahagoni (L.) Jacq., however its antimicrobial activity has not been investigated, yet. This study was conducted to evaluate the antimicrobial activity of these compounds. Minimal Inhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC) were determined against Staphylococcus aureus and Pseudomonas aeruginosa strains. Among five compounds tested, compound 3 (3,4,5,6,7-pentaethyl-1-methoxy-1H-indazole) and compound 4 (5-ethyl-6-methoxymethyl-2-methyl-1,2-dihydropyridine) were found to be active against the bactrial strains tested with the MICs and MBCs values ranged from 50 to 100 μg/mL. In conclusion, among five compounds isolated from S. mahagoni (L.) Jacq., compound 3 and 4 showed moderate antimicrobial activity against S. aureus and P. aeruginosa strains.
INTRODUCTION
Infectious diseases still become a major health problem in developing and developed countries. They are leading cause of illness and death throughout the world. According to the Special Programme for Research and Training in Tropical Diseases, World Health Organization (TDR-WHO), infectious diseases kill 3.5 million people annually, mostly the poor and young children who live in low and middle income in countries. 1 Antibiotics are commonly used to treat of the infectious diseases. However, irrational use of antibiotics in the treatment of the diseases has led to the development of widespread bacterial resistance to antibiotics which becoming increasingly more difficult to treat the infectious diseases with currently available antibiotics. 2 Face of growing antibiotics resistance, a strategy is needed to discover and develop new antibiotics. 3 In the past few decades, the searh for new antimicrobial agents has occupied many research groups in the field of ethnopharmacology. Many medicinal plants from different part of the world have been studied. 4 Swietenia mahagoni (L.) Jacq., locally known as the mahoni, belonging to the family Meliaceae, is one of potential medicinal plants as a source new antimicrobial agents that extensively investigated. The flower, leaf and bark extract of S. mahagoni (L.) Jacq. showed activity against Gram positive and Gram negative bacteria. 5, 6 Moreover, the seed extract S. mahagoni (L.) Jacq. was active against Bacillus subtillis, Sarcina lutea, Xanthomonas campestris, Klebsiella pneumoniae, and Escherichia coli. 7 In order to find out new antimicrobial agents, five compounds have been isolated from an ethanolic extract of S. mahagoni (L.) Jacq. (FIGURE 1) included 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-chromen-4-one (compound 1), 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline (compound 2), 3,4,5,6,7-pentaethyl-1-methoxy-1H-indazole (compound 3), 5-ethyl-6-methoxymethyl-2-methyl-1,2-dihydropyridine (compound 4) and 1,4-bis (3,4,5-trimethoxy-phenyl)-tetrahydrofuro(3,4-c)furan (compound 5). In this study we reported the antimicrobial activity of these compounds against Staphylococcus aureus and Pseudomonas aeruginosa strains.
MATERIALS AND METHODS

Bacterial strains
The test bacteria employed in this study i.e. methicillin resistant S. aureus (MRSA), S. aureus (ATCC 25923), P. aeruginosa clinical isolate, and P. aeruginosa (ATCC 27853) were obtained from the Department of Microbiology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta. These bacterial strains were maintained in viable state via inoculation on Brain Heart Infusion Double Strength (BDHI DS) media and overnight incubation at 37°C.
Tested compounds
The tested compounds were isolated from an ethanolic extract of S. mahagoni (L.) Jacq. seed by Dra. Mursiti, MSi. from the Department of Chemistry, Universitas Negeri Semarang. The structure of these tested compounds are presented in FIGURE 1. 
Antimicrobial activity determination
Minimal Inhibitory Concentration (MIC) determination. The MIC of tested compounds was determined using the tube dilution method. Bacterial colonies were picked from freshly culture plates and diluted with Brain Heart Infusion Double Strength (BDHI DS) media to final concentration of 10 6 CFU/mL. Serial dilution of the tested compounds ranged from 1.56 to 800.00 µg/mL were prepared by diluting the stock solution with BHI DS media. One mL of the diluted bacterial suspension was added to tube containing one mL of serial the tested compounds dilution to yield the appropriate density 5 x 10 5 CFU/mL. The tubes were then incubated for 24 h at 37 o C. As negative control was a tube containing the diluted bacterial suspensions without the tested compounds, whereas as positive control was a tube containing the diluted bacterial suspensions with levofloxacin. The MICs were defined as the lowest concentration of the tested compounds that completely inhibits the growth of the organism as detected by the unaided eye. All MIC determination were conducted three times on independent experiments.
Minimal Bactericidal Concentration (MBC) determination. The bactericidal activities of the tested compounds were determined on the methicillin resistant S. aureus and P. aeruginosa clinical isolates. The suspentions of all the macroscopically clear tubes were inoculated onto plates of blood agar and were then incubated for 24 h at 37 °C. As control was a tube containing sterile distilled water and no the tested compounds were included. At the end of the incubation, the number of bacteria was counted in each of the tubes and was compared with the number of bacteria of the control tube. The MBCs were defined as the lowest concentration giving 0.1% bacterial survival. 8 The MICs values of the tested compounds are presented in TABLE 1. Among the five tested compounds, two compounds i.e. compound 3 and 4 showed antimicrobial activity against the bacterial strains tested. The compound 3 showed highest activity against P. aeruginosa (ATCC 27853) strain with the MIC value of 50 μg/mL, whereas the compound 4 showed highest activity against both S. aureus (ATCC 25923) and P. aeruginosa (ATCC 27853) strains with the MICs values of 50 μg/mL. However, the MICs of the compound 3 and 4 were lower than the MIC of levofloxacin (1 -4 μg/mL) as positive control. The MBCs values of the tested compounds are presented in TABLE 2. The MBCs values of the compound 3 and 4 were similar with its MICs values. The MBCs of these two compounds were also lower than the MBCs of the levofloxacin ((1 -4 μg/mL). 
RESULTS
Antimicrobial activity of the tested compounds was investigated in vitro against
DISCUSSION
Various parts of Swietenia mahagoni (L.) Jacq. have been used traditionally for the treatment of hypertension, diabetes, malaria, amoebiasis, coughs, tuberculosis, antiseptic, astringent, diarrhea, and tonic. [9] [10] [11] Swietenia mahagoni (L.) Jacq. seeds are also reported to have medicinal value for the treatment of hypertension, diabetes, malaria, 12 cancer, amoebiasis, coughs and intertinal parasitism. 13 Furthermore, the seed extract S. mahagoni (L.) Jacq. have been accounted to possess antimicrobial activity. 7 In these study we have tested the antimicrobial activity of five compounds isolated from S. mahagoni (L.) Jacq. Among the five compounds tested, two compounds i.e. compound 3 and 4 showed antimicrobial activity against S. aureus and P. aeruginosa strains tested with the MICs and MBCs values ranged from 50 to 100 μg/mL. The MICs and MBCs values of these compound 3 and 4 were lower than the MICs and MBCs values of levofloxacin (1-4 μg/mL) as positive control indicating the antimicrobial activity of these compounds were moderate.
Some bioactive compounds have been isolated from S. mahagoni (L) Jacq. and their antimicrobial activity has been investigated. Kader et al. 7 isolated two limonoids, swietenine and 3-O-tigloylswietenolide from the chloroform soluble fraction of an ethanolic extract of S. mahagony (L) Jacq. seeds and evaluated its antimicrobial activity against a series of Gram positive and Gram negative bacteria. The most potent antimicrobial activity of these compounds were against B. megatorium and E. coli. Ghosh et al. 14 isolated other limonoids i.e. swietenolide and 2-hydroxy-3-O-tigloylswietenolide and also evaluated its antimicrobial activity against eight multiple-drugresistant bacterial strains including Gram positive and Gram negative bacteria. 2-Hydroxy-3-Otigloylswietenolide had, overall, more potent activity than swietenolide. The most potent antibacterial activity of swietenolide was against Haemophilus influenzae, Salmonella typhi, and Salmonella paratyphi, and 2-hydroxy-3-O-tigloylswietenolide was most active against Streptococcus pneumoniae, Salmonella typhi, and Salmonella paratyphi. Both the compounds were least effective against Klebsiella pneumoniae.
Both of the compound 3 (3,4,5,6,7-pentaethyl-1-methoxy-1H-indazole) and compound 4 (5-ethyl-6-methoxymethyl-2-methyl-1,2-dihydropyridine) are a class of alkaloids which are well known for their wide range of pharmacological activities including antimicrobial activity. 15, 16 Although the antimicrobial activity of the compound 3 and compound 4 were found to be moderate, however the antimicrobial activity of these compounds have not been reported, yet. Therefore, these compounds could be used as starting points for new antimicrobial discovery.
CONCLUSION
In conclusion, among five compounds isolated from S. mahagoni (L.) Jacq., compound 3 (3,4,5,6,7-pentaethyl-1-methoxy-1H-indazole) and compound 4 (5-ethyl-6-methoxymethyl-2-methyl-1,2-dihydropyridine) showed moderate antimicrobial activity against S. aureus and P. aeruginosa.
